#LCSM Chat 5/26: Top 10 Key Abstracts on Lung Cancer (and Mesothelioma) at ASCO 2016: An #LCSM Preview
By Jack West, MD For the upcoming #LCSM chat on Thursday, 5/26 at 8 PM Eastern (5 PM Pacific) we’re going to do a preview of what are likely to be the most notable and clinically relevant presentations in lung cancer, and one in mesothelioma, at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago in early June. This meeting brings together over 30,000 cancer specialists every year to review thousands of presentations. Nobody can see it all, and one important aspect of not being overwhelmed is knowing what should… Read More
#LCSM Chat 5/5: Know Before You Go—Conference Prep 101
Lung cancer patients and advocates are increasingly joining healthcare, pharma, government agency and biotech industry representatives at cancer-related medical conferences such as the American Association for Cancer Research (AACR) Annual Meeting in April and the American Society for Clinical Oncology Annual Meeting in June. Planning ahead for these meetings is essential for getting the most out of your time. The events, which can last several days, often have many sessions happening at the same time in different rooms. In addition to scheduling considerations, the terminology, graphics, and scientific concepts discussed in the… Read More
How Can We Overcome Hurdles in Clinical Lung Cancer Research?
By H Jack West, MD People with lung cancer today benefit from a growing range of new cancer treatments that provide the promise of dramatic and long-lasting responses. Whether refinements in our chemotherapy, new targeted therapies, exciting immunotherapy strategies, or other novel agents or combinations, the development of these advances is exciting and based on the completion of important clinical trials. The investigators running trials of novel agents, as well as the companies developing them and the research groups helping to manage them, are eager to enroll on these studies and learn… Read More
#LCSM 
You must be logged in to post a comment.